Michelle Mitchell OBE joined in November 2018. She is responsible for the overall leadership and management of CRUK, the world’s leading charitable funder of cancer research.

Since taking the helm, Michelle has helped put CRUK on a strong footing to achieve its vision of bringing about a world where everyone can lead longer, better lives, free from the fear of cancer. Having navigated the COVID-19 pandemic, she set the organisation on an ambitious new course with its long-term strategy, launched shortly after CRUK celebrated its 20th anniversary. In 2022/23, Michelle led the charity in delivering one of the strongest impact and financial performances in its history.

Michelle is a senior voluntary sector leader who has transformed a number of not-for-profit organisations to better their purpose and global impact. She has a successful track record of delivering long term value, collaboration and innovation. She is a member of the National Cancer Board (England) and the NHS Genomics Board (England).

Before joining Cancer Research UK, Michelle was CEO of the MS Society for five years and a founding member of the Progressive MS Alliance: a global scientific and research joint venture and launched the STOP MS £100m appeal. Prior to that, she was Director General at Age UK, the UK’s largest older people’s charity where she worked for nearly a decade and was at the forefront of national debates on health, care and welfare.
Michelle has extensive non-executive experience, which has included NED at NHS England, which sets the priorities and direction for the NHS in England and a Trustee of the King’s Fund, a leading health policy think-tank. Michelle has a BA in Economics, an MA in Politics and Public Administration and an International Executive Diploma from INSEAD. She is an Honorary Fellow of the University of Cambridge’s Homerton College.

Michelle was awarded an OBE in 2015 for services to the charity sector.